Search alternatives:
terms decrease » teer decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
12 a » 12 _ (Expand Search), 12 h (Expand Search), 1 a (Expand Search)
terms decrease » teer decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
12 a » 12 _ (Expand Search), 12 h (Expand Search), 1 a (Expand Search)
-
1
-
2
-
3
HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching.
Published 2015“…<p><b>A,B:</b> Gene knockdown of EZH2 and SUZ12 was confirmed by qPCR. …”
-
4
-
5
-
6
-
7
Characterization of the optimized nanoparticles (These values are means of a minimum of 5 batches).
Published 2015Subjects: -
8
-
9
-
10
Decrease of myopia progression with 0.025% atropine
Published 2018“…<p></p><p>Abstract Purpose: To demonstrate the efficacy of 0.025% atropine eyedrops in myopic children in Brazil for decreasing myopia progression Methods: This was a prospective study with 60 children from Hospital Geral Universitário and Oftalmocenter Santa Rosa in Cuiabá, MT, Brazil, aged between 6 to 12 years, with spherical equivalent refractive error of -1.00 to -6.00 diopters (D) and astigmatism of -1.00 D or smaller. …”
-
11
-
12
-
13
-
14
-
15
-
16
Baseline characteristics of study participants.
Published 2025“…For each age group, the mumps IgG seroprevalence rates were 74.40%, 89.02%, 85.58%, 68.60%, 69.28%, 78.42%, and 80.63% for those <8 months, 8 months-2 years, 3–5 years, 6–17 years, 18–39 years, 40–59 years, and>=60 years, respectively. In terms of the percentage decreases in anti-mumps antibody titers, in the population receiving the 1-dose vaccine, there was a mean decrease of 2.06% per year. …”
-
17
The numerical data used in this study.
Published 2025“…For each age group, the mumps IgG seroprevalence rates were 74.40%, 89.02%, 85.58%, 68.60%, 69.28%, 78.42%, and 80.63% for those <8 months, 8 months-2 years, 3–5 years, 6–17 years, 18–39 years, 40–59 years, and>=60 years, respectively. In terms of the percentage decreases in anti-mumps antibody titers, in the population receiving the 1-dose vaccine, there was a mean decrease of 2.06% per year. …”
-
18
-
19
-
20